• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡氏肺孢子虫肺炎:获得性免疫缺陷综合征患者与其他免疫缺陷患者的比较。

Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies.

作者信息

Kovacs J A, Hiemenz J W, Macher A M, Stover D, Murray H W, Shelhamer J, Lane H C, Urmacher C, Honig C, Longo D L

出版信息

Ann Intern Med. 1984 May;100(5):663-71. doi: 10.7326/0003-4819-100-5-663.

DOI:10.7326/0003-4819-100-5-663
PMID:6231873
Abstract

Clinical features of 49 episodes of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome were compared with those of 39 episodes in patients with other immunosuppressive diseases. At presentation patients with the syndrome were found to have a longer median duration of symptoms (28 days versus 5 days, p = 0.0001), lower mean respiratory rate (23.4 versus 30, p = 0.005), and higher median room air arterial oxygen tension (69 mm Hg versus 52 mm Hg, p = 0.0002). The survival rate from 1979 to 1983 was similar for the two groups (57% and 50% respectively). Patients with the syndrome had a higher incidence of adverse reactions to trimethoprim-sulfamethoxazole (22 of 34 versus 2 of 17, p = 0.0007). Survivors with the syndrome at initial presentation had a significantly lower respiratory rate, and higher room air arterial oxygen tension, lymphocyte count, and serum albumin level compared to nonsurvivors. Pneumocystis carinii pneumonia presents as a more insidious disease process in patients with the syndrome, and drug therapy in these patients is complicated by frequent adverse reactions.

摘要

对49例获得性免疫缺陷综合征患者的卡氏肺孢子虫肺炎发作的临床特征与39例其他免疫抑制疾病患者的发作特征进行了比较。在就诊时发现,综合征患者的症状中位持续时间更长(28天对5天,p = 0.0001),平均呼吸频率更低(23.4对30,p = 0.005),且室内空气动脉血氧分压中位数更高(69毫米汞柱对52毫米汞柱,p = 0.0002)。1979年至1983年两组的生存率相似(分别为57%和50%)。综合征患者对甲氧苄啶-磺胺甲恶唑的不良反应发生率更高(34例中的22例对17例中的2例,p = 0.0007)。与非幸存者相比,初次就诊时患有综合征的幸存者呼吸频率显著更低,室内空气动脉血氧分压、淋巴细胞计数和血清白蛋白水平更高。卡氏肺孢子虫肺炎在综合征患者中表现为一种更隐匿的疾病过程,并且这些患者的药物治疗因频繁的不良反应而变得复杂。

相似文献

1
Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies.卡氏肺孢子虫肺炎:获得性免疫缺陷综合征患者与其他免疫缺陷患者的比较。
Ann Intern Med. 1984 May;100(5):663-71. doi: 10.7326/0003-4819-100-5-663.
2
Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome.获得性免疫缺陷综合征患者对甲氧苄啶-磺胺甲恶唑的不良反应。
Ann Intern Med. 1984 Apr;100(4):495-9. doi: 10.7326/0003-4819-100-4-495.
3
The treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.获得性免疫缺陷综合征中卡氏肺孢子虫肺炎的治疗
Arch Intern Med. 1985 May;145(5):837-40.
4
Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial.甲氧苄啶-磺胺甲恶唑或喷他脒治疗获得性免疫缺陷综合征患者的卡氏肺孢子虫肺炎。一项前瞻性随机试验。
Ann Intern Med. 1986 Jul;105(1):37-44. doi: 10.7326/0003-4819-105-1-37.
5
Clinical features of Pneumocystis pneumonia in the acquired immune deficiency syndrome.获得性免疫缺陷综合征中肺孢子菌肺炎的临床特征
Am Rev Respir Dis. 1984 Oct;130(4):689-94. doi: 10.1164/arrd.1984.130.4.689.
6
Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study.甲氧苄啶-磺胺甲恶唑与喷他脒治疗获得性免疫缺陷综合征患者卡氏肺孢子虫肺炎的比较。一项前瞻性、非交叉研究。
Ann Intern Med. 1988 Aug 15;109(4):280-7. doi: 10.7326/0003-4819-109-4-280.
7
Desensitization to trimethoprim sulfamethoxazole in patients with acquired immune deficiency syndrome and Pneumocystis carinii pneumonia.
Ann Allergy. 1989 Mar;62(3):177-9.
8
Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone.获得性免疫缺陷综合征中卡氏肺孢子虫肺炎的口服治疗。甲氧苄啶-磺胺甲恶唑与甲氧苄啶-氨苯砜的对照试验。
N Engl J Med. 1990 Sep 20;323(12):776-82. doi: 10.1056/NEJM199009203231202.
9
Drug treatment of pneumonia due to Pneumocystis carinii.卡氏肺孢子虫肺炎的药物治疗。
Tex Med. 1987 Feb;83(2):27-30.
10
Therapy of pneumocystis carinii pneumonia after trimethoprim-sulfamethoxazole desensitization.甲氧苄啶-磺胺甲恶唑脱敏后卡氏肺孢子虫肺炎的治疗
Klin Wochenschr. 1989 Mar 1;67(5):316. doi: 10.1007/BF01892903.

引用本文的文献

1
pneumonia in thoracic organ transplantation: Current perspectives and updates.胸器官移植中的肺炎:当前观点与进展
JHLT Open. 2025 Aug 7;10:100367. doi: 10.1016/j.jhlto.2025.100367. eCollection 2025 Nov.
2
Immune responses of different hosts to infection.不同宿主对感染的免疫反应。
Eur Respir Rev. 2025 Jul 9;34(177). doi: 10.1183/16000617.0247-2024. Print 2025 Jul.
3
Diagnostic Challenges of Pneumocystis jirovecii Pneumonia in Methotrexate-Induced Pancytopenia: A Report on a Fatal Case and Review of the Literature.
甲氨蝶呤所致全血细胞减少症合并耶氏肺孢子菌肺炎的诊断挑战:1例死亡病例报告及文献复习
Cureus. 2025 Apr 18;17(4):e82542. doi: 10.7759/cureus.82542. eCollection 2025 Apr.
4
Risk of Pneumonia in Patients With HIV in Taiwan: Evidence from a Cross-sectional Study.台湾地区HIV患者的肺炎风险:一项横断面研究的证据。
In Vivo. 2025 Mar-Apr;39(2):1054-1066. doi: 10.21873/invivo.13910.
5
Prognostic Factors of In-hospital Mortality in Patients without Human Immunodeficiency Virus Infection with Pneumocystis Pneumonia: A Retrospective Cohort Study.无人类免疫缺陷病毒感染的肺孢子菌肺炎患者院内死亡的预后因素:一项回顾性队列研究
Intern Med. 2025 Mar 1;64(5):651-657. doi: 10.2169/internalmedicine.4090-24. Epub 2024 Aug 1.
6
Pneumocystis pneumonia in intensive care: clinical spectrum, prophylaxis patterns, antibiotic treatment delay impact, and role of corticosteroids. A French multicentre prospective cohort study.重症监护病房中的卡氏肺孢子虫肺炎:临床谱、预防模式、抗生素治疗延迟的影响以及皮质类固醇的作用。一项法国多中心前瞻性队列研究。
Intensive Care Med. 2024 Aug;50(8):1228-1239. doi: 10.1007/s00134-024-07489-2. Epub 2024 Jun 3.
7
Clinical and Radiological Features of Pneumonia in Children: A Case Series.儿童肺炎的临床和放射学特征:病例系列
J Fungi (Basel). 2024 Apr 9;10(4):276. doi: 10.3390/jof10040276.
8
pneumonia in people living with HIV: a review.HIV 感染者肺炎:综述。
Clin Microbiol Rev. 2024 Mar 14;37(1):e0010122. doi: 10.1128/cmr.00101-22. Epub 2024 Jan 18.
9
Molecular Analysis of Dihydropteroate Synthase Gene Mutations in Isolates among Bulgarian Patients with Pneumonia.保加利亚肺炎患者分离株中二氢叶酸合成酶基因突变的分子分析。
Int J Mol Sci. 2023 Nov 29;24(23):16927. doi: 10.3390/ijms242316927.
10
Pneumonia after Heart Transplantation: Two Case Reports and a Review of the Literature.心脏移植术后肺炎:两例报告及文献综述
Pathogens. 2023 Oct 21;12(10):1265. doi: 10.3390/pathogens12101265.